Welcome to our dedicated page for Sunopta SEC filings (Ticker: STKL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
SunOpta Inc. (STKL, SOY) is a Canada-incorporated manufacturer of plant-based beverages, broths and better-for-you snacks that files reports with the U.S. Securities and Exchange Commission. As a cross-listed issuer on Nasdaq and the Toronto Stock Exchange, SunOpta uses SEC filings to provide detailed information on its financial condition, results of operations and material events.
Among the key documents available for SunOpta are annual reports on Form 10‑K and quarterly reports on Form 10‑Q, which present revenue from continuing operations, earnings from continuing operations, adjusted earnings, adjusted EBITDA and discussions of volume growth across beverages, broths and fruit snacks. These filings also describe factors affecting gross margins, capital allocation priorities, leverage targets, tariff impacts and the company’s approach to pass-through pricing with customers.
Current reports on Form 8‑K are particularly relevant for tracking SunOpta’s material announcements. For example, the company has filed 8‑Ks to furnish press releases reporting financial results for specific quarters, under Item 2.02 Results of Operations and Financial Condition. These filings link directly to earnings releases that discuss recent performance, updates to revenue and adjusted EBITDA outlooks, and commentary on operational initiatives.
On this page, investors can access SunOpta’s SEC filings as they are made available through EDGAR, along with AI-powered summaries designed to highlight the most important points in lengthy documents. The filings list also provides a path to insider transaction reports on Form 4, as well as proxy and other governance-related filings, helping users analyze SunOpta’s regulatory disclosures, compensation decisions and ownership changes alongside its reported financial results.
SunOpta Inc. (STKL) Form 4 – Director share acquisition
On 07/25/2025, director Rebecca Fisher received additional equity compensation:
- Common shares: 1,916 shares acquired at a deemed price of $6.64 per share (transaction code A). Post-transaction direct ownership rises to 137,999 shares.
- Restricted Stock Units (RSUs): 2,423 RSUs awarded; total RSUs now 20,193. Each RSU converts 1-for-1 into common stock; the units have no expiration date.
The filing notes that the common shares were issued in lieu of cash compensation for board service, signalling an increased equity stake and alignment with shareholders. No dispositions were reported, and the director remains classified as an insider-director only.
SunOpta Inc. (STKL) – Form 4 insider filing dated 28 Jul 2025 reports transactions by director Richard Dean Hollis on 25 Jul 2025.
- Equity received in lieu of cash: 3,534 common shares were issued to Hollis for board service at a stated price of $6.64 per share.
- Post-transaction ownership: Hollis now directly owns 579,888 common shares.
- Derivative grant: 2,423 Restricted Stock Units (RSUs) were awarded, representing a contingent right to receive 20,193 common shares; RSUs carry no exercise price and no stated expiration.
No dispositions occurred and the filing indicates the director remains a non-executive board member. The share issuance is modest relative to Hollis’s existing stake (<1%) and was compensation-related, not an open-market purchase. Overall cash outlay by the insider is zero; nevertheless, the additional equity slightly increases insider alignment with shareholders.
Form 4 snapshot (filed 07/14/2025) for SunOpta Inc. (STKL):
- Reporting insider: Lauren McNamara, SVP Business Management.
- Event date: 07/10/2025.
- RSU conversions (Code M): 1,669 + 679 = 2,348 common shares acquired at $0 exercise cost.
- Share withholding for taxes (Code F): 762 + 310 = 1,072 shares disposed at $6.48 per share to cover statutory withholding.
- Net change: +1,276 shares.
- Ending beneficial ownership: 115,418 common shares held directly.
- Derivative balance: 1,669 & 679 unvested RSUs remain; units vest in three equal annual tranches that began 07/10/2024 and carry no expiration.
No other equity classes, options, or cash transactions were disclosed. Activity appears routine and linked to scheduled RSU vesting rather than open-market trading.